Stephen Antonysamy
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Monoclonal and Polyclonal Antibodies Research, 14-3-3 protein interactions, Epigenetics and DNA Methylation, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Crystal structure of the human PRMT5:MEP50 complex(2012)359 cited
- → Structural analysis of a set of proteins resulting from a bacterial genomics project(2005)246 cited
- → Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene(2018)229 cited
- → LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity(2018)179 cited
- → Aurora A ligand complex(2018)154 cited
- → LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2(2015)131 cited
- → Structural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET Domain(2013)94 cited
- → Fragment-based discovery of JAK-2 inhibitors(2008)79 cited
- → Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics(2015)65 cited
- → Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors(2008)61 cited